HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kiehl’s President Huber To Execute Retail Store Expansion Initiatives

This article was originally published in The Rose Sheet

Executive Summary

Kiehl's newly appointed President Edgar Huber will be tasked with implementing the niche beauty brand's store expansion initiative after assuming the company helm April 15, L'Oréal announced

You may also be interested in...



Kiehl's Heidegger Resigns, New President Taylor Executes Growth Strategy

The operational strategy and foundational values on which niche skin and hair care marketer Kiehl's has been based under the leadership of the Morse-Heidegger family will remain a blueprint for the future, according to incoming President Michelle Taylor.

L'Oreal Kiehl's Acquisition Marks Entry Into Niche Beauty Market

L'Oreal is taking its first step into the niche skin and hair care market with the acquisition of Kiehl's Since 1851, adopting a similar strategy used by its competitors Estee Lauder and LVMH. L'Oreal U.S. subsidiary Cosmair announced the purchase April 17.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel